Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Amicus Therapeutics Inc (FOLD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amicus's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
12.990 +0.240    +1.88%
15:38:02 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 919,671
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 12.750 - 13.095
Amicus 12.990 +0.240 +1.88%

Amicus Therapeutics Inc Company Profile

 
Get an in-depth profile of Amicus Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

496

Equity Type

ORD

Amicus Therapeutics, Inc. is a biotechnology company that is focused on discovering, developing, and delivering medicines for rare diseases. The Company's portfolio is Galafold (migalastat), which is the approved oral precision medicine for people living with Fabry disease. Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A (alpha-Gal A) enzyme in patients with genetic variants. Migalastat is approved under the trade name Galafold in the United States, European Union, United Kingdom and Japan. Its biologics program in its pipeline is Amicus Therapeutics GAA (AT-GAA), which is a clinical-stage treatment paradigm for Pompe disease. Pompe disease is a lysosomal disorder (LD) from deficiency in an enzyme, GAA. AT-GAA consists of a uniquely engineered rhGAA enzyme, ATB200, or cipaglucosidase alfa, with an optimized carbohydrate structure to enhance lysosomal uptake, administered in combination with AT2221 (miglustat) that functions as an enzyme stabilizer.

Contact Information

Address 3675 Market Street
Philadelphia, 19104
United States
Phone 215 921 7600
Fax 215 921 7900
Web amicusrx.com

Top Executives

Name Age Since Title
Michael G. Raab 57 2004 Lead Independent Director
Margaret G. McGlynn 63 2009 Independent Director
Glenn P. Sblendorio 66 2006 Independent Director
Craig A. Wheeler 62 2016 Independent Director
Michael A. Kelly 65 2020 Independent Director
Lynn Dorsey Bleil 59 2018 Independent Director
Burke W. Whitman 66 2019 Independent Director
Eiry Wyn Roberts 58 2021 Independent Director
John F. Crowley 55 2004 Executive Chairman
Bradley L. Campbell 46 2007 CEO, President & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

FOLD Comments

Write your thoughts about Amicus Therapeutics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Crim Jamer
Crim Jamer Jan 10, 2022 2:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I wish i could be the CEO of the company. He sold his stocks accidentally on friday.
Reply
0 0
Report
Crim Jamer
Crim Jamer Jan 10, 2022 2:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I also sold at 8.8 after almost 2 years of bagholding. Now it's up
Reply
0 0
Report
Crim Jamer
Crim Jamer Jan 10, 2022 2:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Crim Jamer now breakout
Reply
0 0
Report
Crim Jamer
Crim Jamer Nov 15, 2021 9:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
04.11 = MA 50 crossed above the MA200
Reply
0 0
Report
Crim Jamer
Crim Jamer Sep 30, 2021 1:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
monthly return= -25%
Reply
0 0
Report
Crim Jamer
Crim Jamer Sep 30, 2021 1:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Been spendin' most their livesLivin' in a shorters's paradise(4x)
Reply
0 0
Report
Hakan YILMAZ
Hakan YILMAZ Mar 11, 2021 3:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
For 2021, the company expects total Galafold revenues of at least $300-$315 million, driven by continued operational growth and commercial execution across all major markets, including the United States, the EU, the U.K. and Japan.
Reply
0 0
Report
Crim Jamer
Crim Jamer Mar 11, 2021 3:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
buying, crashing in 2 days, bagholding for a year to breakeven, crashing in 2 days, repeat
Reply
0 0
Report
Семен Семеныч
Семен Семеныч Feb 25, 2021 3:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
with WH already worked, waiting here
Reply
0 0
Report
Семен Семеныч
Семен Семеныч Feb 25, 2021 2:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
just sent to WSB the offer to try short squuze with WH and FOLD, let's see
Reply
0 0
Report
Ксения Иванова
Ксения Иванова Feb 25, 2021 2:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hahaah tnx
Reply
0 0
Report
Tracy Weintraub
Tracy Weintraub Feb 16, 2021 2:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why is it going down today?
Reply
0 0
Report
Wojciech Stefaniak
Wojciech Stefaniak Jun 08, 2020 2:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Avoid any recommendations (it's monkey business for big) use your brain and intuition, then you save your own money.
Reply
1 0
Report
Miguel Angel Cuña
Cocastrelli Jun 08, 2020 2:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
O co chodzi, Wojciech?
Reply
0 0
Report
Wojciech Stefaniak
Wojciech Stefaniak Jun 08, 2020 2:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Miguel Angel Cuña  I've been investing for more then four years from now. So, I followed, at the begining, recommendations given by so called experts. More then 60% of its were wrong or disapointed me. Now I know that my estimation of stock and intuition is no worse and some times better then experts from banks, etc. I try to follow Buffet's point of view in investing, of course, reading all opinions and recommendations given.
Reply
1 0
Report
Wojciech Stefaniak
Wojciech Stefaniak Oct 02, 2019 9:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I was right: *****and see you next year!
Reply
3 1
Report
Wojciech Stefaniak
Wojciech Stefaniak Sep 05, 2019 7:12AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Going south, 7, 5 or very bottom $2? Amicus=amicable or .... reverse.
Reply
0 3
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email